Cytogenetic characterization of childhood acute lymphoblastic leukemia in Nicaragua

Pediatric Blood and Cancer

Volumn 53, Issue 7, 2009, Pages 1238-1241

  Ceppi, Francesco ^a   Brown, Angela ^b   Betts, David R ^b   Niggli, Felix ^b   Popovic, Maja Beck ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Acute lymphoblastic leukemia; Cytogenetics; Developing countries

Indexed keywords

BCR ABL PROTEIN; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR RUNX1; MIXED LINEAGE LEUKEMIA PROTEIN; MLL PROTEIN, HUMAN; ONCOPROTEIN; TEL AML1 FUSION PROTEIN; TEL-AML1 FUSION PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; BONE MARROW BIOPSY; CHILD; CHROMOSOME ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; HEPATOSPLENOMEGALY; HUMAN; IMMUNOPHENOTYPING; INCIDENCE; INFANT; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; NICARAGUA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; ANEUPLOIDY; CHROMOSOME ABERRATION; CHROMOSOME BANDING PATTERN; GENETICS; HEPATOMEGALY; PROGNOSIS; PROSPECTIVE STUDY; RISK; SPLENOMEGALY;

ADOLESCENT; ANEUPLOIDY; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CORE BINDING FACTOR ALPHA 2 SUBUNIT; FEMALE; FUSION PROTEINS, BCR-ABL; HEPATOMEGALY; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NICARAGUA; ONCOGENE PROTEINS, FUSION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; PROSPECTIVE STUDIES; RISK; SPLENOMEGALY;

EID: 70449717442     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22169     Document Type: Article

References (25)

1. Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med 2004;350:1535-1548.
2. Parkin DN, Stiller CA, Draper GJ, et al. The international incidence of childhood cancer. Int J Cancer 1988;42:511.
3. Metzger ML, Howard SC, Fu LC, et al. Outcome of childhood acute lymphoblastic leukemia in resource-poor contries. Lancet 2003;362:706-708.
4. Wagner HP, Antic V. The problem of pediatric malignancies in the developing world. Ann NYAcad Sci 1997;824:193-204.
5. Magrath I, Shad A, Epelman S, et al. Pediatric oncology in less developed countries. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia, PA: Lippincott; 1993. pp. 1225-1251.
6. Chandy M. Childhood acute lymphoblastic leukemia in India: An approach to management in a three tier society. Med Pediatr Oncol 1995;25:197-203.
7. Pui CH, Evans WE. Acute lymphoblastic leukaemia. N Engl J Med 1998;339:605-615.
8. Look AT. Oncogenic transcription factors in the human acute leukemias. Science 1997;278:1059-1064.
9. Pui C-H, Crist WM. Biology and treatment of acute lymphoblastic leukaemia. J Pediatr 1994;124:491-503.
10. Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukaemia. J Clin Oncol 1996;14:18-24.
11. Maloney KW, Shuster JJ, Murphy S, et al. Long-term results of treatment studies for childhood acute lymphoblastic leukaemia. Pediatric Oncology Group studies from 1986 to 1994. Leukemia 2000;14:2276-2285.
12. Aricò M, Valsecchi MG, Camitta B, et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukaemia. N Engl J Med 2000;342:998-1006.
13. Ito C, Kumagai M, Manabe A, et al. Hyperdiploid acute lymphoblastic leukaemia with 51 to 65 chromosomes: A distinct biological entity with a marked propensity to undergo apoptosis. Blood 1999;93:315-320.
14. Masera G, Baez F, Biondi A, et al. North-south twinning in paediatric haemato-oncology: The La Mascota programme Nicaragua. Lancet 1998;352:1923-1926.
15. Malta A, Baez F, Flores A, et al. Childhood acute lymphoblastic leukemia. Features at the onset in patients in Monza (Italy) and Managua (Nicaragua). Int J Pediatr Hematol Oncol 1997;4:121-125.
16. Betts DR, Koesters R, Pluss HJ, et al. Routine karyotyping in Wilms tumor. Cancer Genet Cytogenet 1997;96:151-156.
17. Tanneberger S, Cavalli F, Pannuti F, editors. Cancer in developing countries. The great Challenge for Oncology in The 21st Century. Munich: Zuckschwerdt Verlang GmbH; 2004. 178 p.
18. Valsecchi MG, Tognoni G, Bonilla M, et al. Clinical epidemiology of childhood cancer in Central America and Carribean countries. Ann Oncol 2004;15:680-685.
19. Silverman LB, Sallan SE. Acute lymphoblastic leukemia. In: Nathan DG, Orkin SH, Ginsburg D, Look AT, editors. Nathan and Oski's hematology of infancy and childhood. Philadelphia: W.B. Saunders; 2003. pp. 1135-1166.
20. Reiter A, Schrappe M, Ludwig WD, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994;84:3122-3123.
21. Johansson B, Mertens F, Mitelman F. Clinical and biological importance of cytogenetic abnormalities in childhood and adult acute lymphoblastic leukaemia. Ann Med 2004;36:492-500.
22. Aldrich M, Zhang L, Wiemels J, et al. Cytogenetics of Hispanic and White Children with ALL in California. Cancer Epidemiol Biomarkers Prev 2006;15:578-581.
23. Macedo Silva ML, Ornellas de Souza MH, Ribeiro RC, et al. Cytogenetic analysis of 100 consecutive newly diagnosed cases of acute lymphoblastic leukemia in Rio de Janeiro. Cancer Genet Cytogenet 2002;137:85-90.
24. Pérez-Vera P, Mújica-Sánchez M, Carnevale A, et al. Cytogenetics in acute lymphoblastic leukemia in Mexican children: An institutional experience. Arch Med Res 2001;32:202-207.
25. Chang HH, Lu MY, Jou ST, et al. Cytogenetics in childhood acute lymphoblastic leukemia in Taiwan: A single-institutional experience. Pediatr Hematol Oncol 2006;23:495-506.